Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

QNCX

QNCX News

Newswire

09:41

Quince Therapeutics shares surge 29.21% intraday following positive safety review for pivotal NEAT Phase 3 trial.

10:17

Quince Therapeutics shares rise 21.12% intraday after management announced December investor events and analysts gave 'Moderate Buy' ratings with $8.00 target price.

10:01

Quince Therapeutics shares rise 11.99% intraday after announcing management's participation in December investor events and receiving "Moderate Buy" ratings from eight analysts with $8.00 target price.

09:44

Quince Therapeutics (QNCX) up more than 100% since Nov 11

09:40

Quince Therapeutics shares jump 16.82% intraday after announcing investor events and Phase 3 NEAT trial updates.

View More

About QNCX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More